GENERAL24 Sept 2026
Medtech firms, hospitals back TMR amid medical device mark-up debate
Medical device makers and private hospitals have backed trade margin rationalisation, or TMR, as a way to narrow the wide gap between procurement costs and the prices consumers pay. Both sides, however, want a fact-based approach that reflects category-specific costs and different procurement structures. For business owners and taxpayers, this matters because device pricing shapes hospital bills and healthcare costs. Follow the final framework before changing any pricing.
Key Statutory Highlights
- Medtech manufacturers and private hospitals have backed trade margin rationalisation, or TMR, as a possible framework.
- They want the approach to be fact-based and to account for category-specific costs and procurement structures.
- TMR is being discussed as a way to address wide gaps between procurement costs and prices charged to consumers.
Actionable Advice for Taxpayers / Founders:If you deal in medical devices or hospital services, keep an eye on how this TMR discussion develops and check the final framework before you revise your pricing or cost assumptions. It may be wise to speak to a tax professional once the details are clear.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: